EQR
37
6
IBM
41
-3
MCO
64
3
KSS
30
-4
AFL
37
3
TGT
56
-2
AVB
52
5
TAP
40
5
FIS
53
3
KEY
31
2
NSC
39
3
VZ
25
3
ILMN
44
6
ZTS
36
7
JPM
56
6
HST
37
2
NDAQ
55
3
MTCH
55
18
VRSK
49
9
HCA
44
7
EQR
37
6
IBM
41
-3
MCO
64
3
KSS
30
-4
AFL
37
3
TGT
56
-2
AVB
52
5
TAP
40
5
FIS
53
3
KEY
31
2
NSC
39
3
VZ
25
3
ILMN
44
6
ZTS
36
7
JPM
56
6
HST
37
2
NDAQ
55
3
MTCH
55
18
VRSK
49
9
HCA
44
7
Financhill
Back

Summit Therapeutics Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
46

SMMT
Summit Therapeutics

Last Price:
$17.88
Seasonality Move:
7.78%
Buy
61

ITCI
Intra-Cellular Therapies

Last Price:
$127.15
Seasonality Move:
2.9%
Sell
46
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $18.18. The Score for SMMT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $127.19. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $18.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $127.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight selling pressure.

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 48.68 Sell
Chaikin Money Flow: 1356879 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.7 - 18.74) Sell
Bollinger Bands (100): (15.6 - 22.64) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.82 Buy
Relative Strength Index (14 RSI): 87.68 Buy
Chaikin Money Flow: -16907827 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.65 - 95.01) Buy
Bollinger Bands (100): (72.96 - 88.08) Buy

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.11 Buy
20-day SMA: 18.21 Sell
50-day SMA: 18.8 Sell
200-day SMA: 12.96 Buy
8-day EMA: 18.17 Buy
20-day EMA: 18.28 Sell
50-day EMA: 18.54 Sell
200-day EMA: 14.22 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 90.14 Buy
20-day SMA: 86.88 Buy
50-day SMA: 86.49 Buy
200-day SMA: 76.02 Buy
8-day EMA: 95.08 Buy
20-day EMA: 89.04 Buy
50-day EMA: 85.45 Buy
200-day EMA: 77.14 Buy

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.16 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):